What Roche Products Ltd, UK does

Roche Products Ltd UK is the UK operating subsidiary of F. Hoffmann-La Roche Ltd, a Swiss-headquartered global healthcare group listed on the SIX Swiss Exchange (ticker: RO). Established in the UK in 1908, the company combines pharmaceutical and diagnostics capabilities under a unified entity structure that includes Roche Products Limited (pharmaceuticals, headquartered at Welwyn Garden City), Roche Diagnostics Limited, and Roche Diabetes Care Limited (both operating from a National Distribution Centre in Burgess Hill, West Sussex). The UK business employs over 2,000 people across more than 50 nationalities and serves NHS trusts, healthcare professionals, patients, and patient organisations as its primary customer base.

The product portfolio spans pharmaceutical medicines for oncology, immunology, ophthalmology, multiple sclerosis, neuromuscular conditions, and rare indications (including haemophilia and spinal muscular atrophy), alongside in vitro diagnostic tests and instruments ranging from bedside devices to large hospital laboratory systems, diabetes care products under the Accu-Chek and CoaguChek sub-brands, and AI-enabled digital diagnostic solutions. Notable technology components include NLP-powered genomic data extraction (the Genomic Information Finder, developed with GOSH DRIVE), computer-vision-based pathology interpretation, and clinical decision-support algorithms. In July 2024, the diagnostics entity expanded its point-of-care capabilities through the acquisition of LumiraDx UK Ltd and related entities.

Revenue is generated through three principal streams: pharmaceutical sales via NHS prescription channels, hardware sales of diagnostic instruments and reagents to NHS hospitals and laboratories, and recurring digital health and subscription solutions. The go-to-market is enterprise field sales with deep NHS collaborative working partnerships. Pricing is not publicly disclosed. The company is ABPI-compliant, holds five ISO certifications (27001, 9001, 14001, 45001, 22301), and operates under NHS framework agreements as the dominant UK market channel.

Name

Roche Products Ltd, UK

Legal name

Roche Products Limited

Website

https://roche.co.uk

Company type

Public

Founded year

1896

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Roche Products Ltd UK is the UK subsidiary of Swiss pharmaceutical and diagnostics group F. Hoffmann-La Roche Ltd, combining pharmaceutical medicines, in vitro diagnostic tests and instruments, AI-enabled digital diagnostics, and diabetes care products, serving NHS trusts, healthcare professionals, patients, and patient organisations across the UK and Ireland.

Ownership category

akta.pro rank

Product category

Pharmaceutical and Diagnostic Products

NAICS

Pharmaceutical and Medicine Manufacturing (32541), In-Vitro Diagnostic Substance Manufacturing (325413), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Oncology Specialty Pharmaceuticals (HLAIACAA)

akta.pro secondary industries

Immunology & Autoimmune Specialty Pharmaceuticals (HLAIACAB), Neurology & CNS Specialty Pharmaceuticals (HLAIACAC), Neurology & Psychiatry (CNS) Pharmaceuticals (HLAIAAAF)

Keywords

• Pharmaceutical medicines
• In vitro diagnostics
• Diagnostic instruments
• Digital health solutions
• Clinical diagnostics

Headquarters

HQ city

Welwyn Garden City

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Others

Revenue model

1. Pharmaceutical products: Development and sale of innovative medicines for oncology, immunology, ophthalmology, multiple sclerosis, neuromuscular conditions, and rare indications. Revenue generated through NHS prescriptions and direct sales.
2. Diagnostic tests and instruments: Sale of in vitro diagnostic tests, instruments and analysers to NHS hospitals, laboratories and healthcare providers. Instruments range from small bedside devices to large laboratory systems.
3. Digital health solutions: Digital solutions supporting specialists in diagnostic work including AI-powered diagnostic interpretation tools and clinical decision support systems.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Roche Products Ltd UK develops, manufactures and supplies innovative pharmaceutical medicines for serious diseases in oncology, immunology, ophthalmology, multiple sclerosis, neuromuscular conditions and rare indications, alongside in vitro diagnostic tests, diagnostic instruments (from bedside to high-throughput laboratory systems), and AI-powered digital health solutions. Products are sold primarily to the NHS, hospital laboratories and healthcare professionals across the UK and Ireland, supported by field-based technical teams and a National Distribution Centre in Burgess Hill.

Product overview

Roche Products Ltd UK operates as a unified pharmaceutical and diagnostics company combining pharmaceuticals and diagnostics capabilities. The core product portfolio includes pharmaceutical medicines (treatments for oncology, immunology, ophthalmology, multiple sclerosis, neuromuscular conditions, and rare indications) and diagnostic solutions (in vitro tests, diagnostic instruments, and digital health solutions). These are complemented by diabetes care products under the Accu-Chek and CoaguChek sub-brands, and the AI-powered Genomic Information Finder for genomic data extraction. The company also provides grants to support patient organisations and maintains an electronic medicines compendium for UK prescribing information. Roche UK is part of the broader Roche Group which includes Roche Diagnostics Limited, Roche Diabetes Care Limited, and LumiraDx UK Limited (acquired July 2024).

Differentiator

Problem solved

Functional benefit

Brands

• Accu-Chek: Blood glucose monitoring systems, diabetes management apps, and insulin delivery systems for patients with diabetes.
• CoaguChek

Products and services

• Pharmaceutical Medicines

Quantifiable outcome

• Reduction in systolic blood pressure by 5 mm Hg reduces risk of major cardiovascular events by about 10%
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Great Ormond Street Hospital NHS Trust (GOSH DRIVE)coreStrategic or Co-development PartnerRoche's partnership with GOSH DRIVE developed the Genomic Information Finder (GIF), an AI-powered tool using Natural Language Processing to automate extraction of key genomic insights from reports. Extracts data in hours rather than months, potentially transforming how genomic data is accessed and used for research and patient care.
• Social Value PortalcoreStrategic or Co-development PartnerExclusive partnership to develop Roche UK's Social Value strategy. Priorities centred around social mobility, healthy community, and healthy planet. Using Social Value Portal's online platform to measure, manage and maximise contribution to UK society. Target of £200 million social value by end of 2026.
• Chugai Pharma UK LtdcoreStrategic or Co-development PartnerCo-promotion agreement in place between Roche Products Ltd and Chugai Pharma UK Ltd. Both companies independently disclose their contributions in accordance with ABPI requirements.
• Association of British Pharmaceutical Industries (ABPI)minorOthersRoche Products Ltd is a member of ABPI. Members are governed by Code of Conduct ensuring professional work with integrity, transparency about engagement with others.
• Association of British HealthTech Industries (ABHI)minorOthersRoche UK is a member of ABHI for diagnostics. Trade body membership ensures adherence to professional codes of conduct beyond legal requirements.
• European Medicines Group (EMG)minorOthersRoche Products Ltd is a member of EMG, working with trade body on improving patient access to innovative medicines and supporting NHS to deliver high-quality care.
• Confederation of British Industries (CBI)minorOthersRoche Products Ltd is a member of CBI. Plays active role in key issues including improving patient access to innovative medicines and supporting wider life science sector in UK.
• NHS Trusts (Multiple)coreStrategic or Co-development PartnerMultiple collaborative working projects with NHS trusts including: The Christie NHS Trust (programme management), Great Ormond Street Hospital (clinical informatics), Bradford Teaching Hospitals (retinal screening), Newcastle Hospitals (AI diagnostics), various breast cancer projects, MS HES dashboard, and influenza pathway optimisation. Projects span MDT approaches, clinical trials, AI diagnostics, and pathway development.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• AstraZeneca UK: UK pharmaceutical subsidiary of AstraZeneca, one of the largest pharma companies in the UK with major oncology, cardiovascular, and respiratory franchises and deep NHS partnerships — directly comparable to Roche UK in scale, therapeutic focus, and NHS go-to-market model.
• Novartis UK: UK operations of Swiss-headquartered Novartis, with overlapping portfolios in oncology, ophthalmology, and rare diseases (including MS therapies). Direct competitor for NHS contracts, ABPI membership, and access to the same NHS formulary and NICE pathways.
• Pfizer UK: UK subsidiary of US-headquartered Pfizer, with broad pharma portfolio across oncology, vaccines, inflammation/immunology, and rare disease — competing head-to-head with Roche UK in oncology and increasingly in personalised healthcare approaches.
• GSK UK: UK-headquartered global pharma with major UK R&D and commercial operations across respiratory, HIV, oncology, and vaccines — directly comparable in NHS partnership model, ABPI membership, and diversified pharma-distribution footprint.
• Merck Sharp & Dohme (MSD) UK: UK subsidiary of Merck & Co. with strong oncology (Keytruda-led) and vaccines franchises, plus a mature NHS engagement model — competes directly with Roche UK across multiple oncology indications and NHS pathway collaborations.
• Sanofi UK: UK operations of Sanofi with broad pharma and vaccines portfolio, including immunology (Dupixent) and rare disease units — comparable scale and similar NHS enterprise sales motion to Roche UK.
• Eli Lilly UK: UK subsidiary of Eli Lilly competing in oncology, diabetes (relevant to Roche Diabetes Care), immunology, and rare diseases — significant UK commercial presence and NHS engagement comparable to Roche UK.
• Bayer UK: UK subsidiary operating Bayer's pharma division (cardiovascular, women's health, oncology) and radiology business — comparable in offering a combined pharma-and-diagnostics commercial model in the UK, including point-of-care imaging presence.
• Abbott UK (Diagnostics + Diabetes Care): UK operations of Abbott span diagnostics (core lab, point-of-care, rapid diagnostics) and diabetes care (FreeStyle Libre), directly overlapping with Roche Diagnostics Limited and Roche Diabetes Care Limited — closest direct competitor in the diagnostics + diabetes care segments in the UK.

Emerging players

• Siemens Healthineers UK: UK presence of Siemens Healthineers focused on in-vitro diagnostics, lab automation, and digital health for hospital systems — competing with Roche Diagnostics Limited for NHS laboratory contracts and digital pathology deployments, although with a narrower specialty pharma footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/RochePharmaUK

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Roche Products Ltd, UK